https://www.thebodypro.com/category/hiv-treatment-strategies/tag/conference-coverage
HIV Treatment Strategies

Conference Coverage

The Latest

Barbed wire fence layed around prison walls

Coordinating Re-Entry Care Is Essential for Incarcerated People With HIV

Re-entry planning can help prevent opioid overdose and enable people living with HIV to connect with and stay in care.

A genderqueer person receiving menstrual products from a nurse

Nurses' Beliefs and Attitudes Toward Transgender Patients Affect Care

Transgender people face discrimination in many facets of life. When it comes to discrimination in clinical settings, it can affect their health for the worse.

Black patient discussing treatment options with a nurse

Black Women Living With HIV Deserve Care Tailored to Them

A systematic review of research between 2000 and 2016 found no studies of interventions specifically designed to support medication adherence among HIV-positive black women.

Several Medication Pill Bottles On Table In Front Of Windows

Patients With HIV Should Think About How Many Pills They Take a Day

Taking more than five medications could be a problem. And many people with HIV are at risk of being on medication overload.

Medical: Pills and Syringe

Two-Drug Regimen Is Being Studied as a Long-Acting Injectable. But Does It Work as a Daily Pill?

New analysis of the LATTE trial shows the two drugs cabotegravir and rilpivirine may also work as a daily oral formulation, which could be a bridge therapy for people who miss an injectable appointment.

A transgender woman in a hospital gown being treated by a doctor, a transgender man

Best Practices for Most Vulnerable Populations: Transgender People, Adolescents, and the Recently Incarcerated

"As we think about the care cascade, we can't even test people [for HIV] to diagnose them if we can't get them in the door to a health care setting," one clinician said.

pill bottles on page full of data

Two-Drug HIV Regimen Works Well Except in People With Low CD4 Count, Study Finds

The combination of dolutegravir and lamivudine is effective for treatment-naive patients regardless of age, gender, or race, according to a new subgroup analysis of the GEMINI clinical studies.

Washington DC at sunset, including Washington Monument

IDWeek 2019: What to Expect at This Year's Conference

We're covering the latest news and research from this major interdisciplinary meeting on infectious diseases, which takes place in Washington, D.C., from Oct. 2 to Oct. 6.

Full panel for HIV Treatment Research: New Drugs and More Efficient Regimens press conference

What's New in HIV Treatment: A Report on Updates from IAS 2019

Researchers reported hopeful news on regimens with lower treatment burdens and newly developed antiretrovirals.

Steven Deeks, M.D.

The State of Cure Research for HIV and Hepatitis B: Similarities and Differences

Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.